Mosaic ImmunoEngineering Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Oct '24 Oct 25, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	May '20 May 31, 2020
Market Capitalization	7	4	7	7	3	-
Market Cap Growth	-43.00%	-39.39%	-2.75%	181.52%	-	-
Enterprise Value	8	5	8	8	2	-
Last Close Price	0.90	0.60	0.99	1.02	3.25	-
PE Ratio	-	-4.29	-3.00	-1.85	-1.69	-
PB Ratio	-0.64	-0.74	-1.47	-2.63	-6.20	-
P/FCF Ratio	-9.97	-8.73	-10.39	-10.85	-6.04	-
P/OCF Ratio	-9.97	-8.73	-10.39	-10.85	-6.04	-
EV/EBIT Ratio	-4.78	-3.85	-3.04	-2.20	-1.52	-
EV/FCF Ratio	-13.04	-10.83	-11.56	-11.32	-5.02	-
Debt / Equity Ratio	-0.22	-0.22	-0.25	-0.26	-	-
Debt / FCF Ratio	-3.41	-2.65	-1.78	-1.08	-	-
Quick Ratio	0.00	0.03	0.06	0.10	0.46	0.56
Current Ratio	0.00	0.04	0.07	0.12	0.52	0.56
Return on Assets (ROA)	-370.30%	-396.93%	-618.80%	-601.74%	-	-
Earnings Yield	-18.94%	-23.20%	-33.21%	-49.97%	-55.13%	-
FCF Yield	-10.03%	-11.45%	-9.63%	-9.21%	-16.56%	-
Buyback Yield / Dilution	-0.00%	-0.01%	-7.79%	-792.16%	-	-
Total Shareholder Return	-0.00%	-0.01%	-7.79%	-792.16%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.